132 related articles for article (PubMed ID: 21167248)
1. New insights into pattern recognition receptors and their ligands in gynecologic pathologies.
Yamada Y; Shigetomi H; Onogi A; Haruta S; Kawaguchi R; Yoshida S; Furukawa N; Nagai A; Tanase Y; Tsunemi T; Oi H; Kobayashi H
Hum Immunol; 2011 Mar; 72(3):213-8. PubMed ID: 21167248
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of endometriosis-associated clear cell carcinoma of the ovary (review).
Kobayashi H; Kajiwara H; Kanayama S; Yamada Y; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Oncol Rep; 2009 Aug; 22(2):233-40. PubMed ID: 19578761
[TBL] [Abstract][Full Text] [Related]
3. A potential link of oxidative stress and cell cycle regulation for development of endometriosis.
Shigetomi H; Higashiura Y; Kajihara H; Kobayashi H
Gynecol Endocrinol; 2012 Nov; 28(11):897-902. PubMed ID: 22591187
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of osteopontin in clear cell carcinoma of the ovary: close association with HNF-1beta expression.
Kato N; Motoyama T
Histopathology; 2008 May; 52(6):682-8. PubMed ID: 18393978
[TBL] [Abstract][Full Text] [Related]
5. Integrating modern approaches to pathogenetic concepts of malignant transformation of endometriosis.
Kobayashi H; Yamada Y; Kawahara N; Ogawa K; Yoshimoto C
Oncol Rep; 2019 Mar; 41(3):1729-1738. PubMed ID: 30592289
[TBL] [Abstract][Full Text] [Related]
6. Clear cell carcinoma of the ovary: potential pathogenic mechanisms (Review).
Kajihara H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sado T; Oi H; Kobayashi H
Oncol Rep; 2010 May; 23(5):1193-203. PubMed ID: 20372830
[TBL] [Abstract][Full Text] [Related]
7. Theoretical model of treatment strategies for clear cell carcinoma of the ovary: focus on perspectives.
Yoshida S; Furukawa N; Haruta S; Tanase Y; Kanayama S; Noguchi T; Sakata M; Yamada Y; Oi H; Kobayashi H
Cancer Treat Rev; 2009 Nov; 35(7):608-15. PubMed ID: 19665848
[TBL] [Abstract][Full Text] [Related]
8. The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary.
Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Int J Gynecol Cancer; 2009 Apr; 19(3):471-9. PubMed ID: 19407577
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms linking endometriosis under oxidative stress with ovarian tumorigenesis and therapeutic modalities.
Shigetomi H; Tsunemi T; Haruta S; Kajihara H; Yoshizawa Y; Tanase Y; Furukawa N; Yoshida S; Sado T; Kobayashi H
Cancer Invest; 2012 Jul; 30(6):473-80. PubMed ID: 22530740
[TBL] [Abstract][Full Text] [Related]
10. Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary.
Yamada Y; Shigetomi H; Onogi A; Haruta S; Kawaguchi R; Yoshida S; Furukawa N; Nagai A; Tanase Y; Tsunemi T; Oi H; Kobayashi H
Int J Gynecol Cancer; 2011 Oct; 21(7):1200-7. PubMed ID: 21885986
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.
Okamoto T; Mandai M; Matsumura N; Yamaguchi K; Kondoh H; Amano Y; Baba T; Hamanishi J; Abiko K; Kosaka K; Murphy SK; Mori S; Konishi I
Mol Carcinog; 2015 Jan; 54(1):35-49. PubMed ID: 24105991
[TBL] [Abstract][Full Text] [Related]
12. Alterations in β-catenin, microsatellite instability, and HNF-1β levels are independently associated with ovarian endometriosis-associated tumorigenesis.
Tomohiro M; Matsumoto T; Miura R; Oguri Y; Yokoi A; Tochimoto M; Saegusa M
Hum Pathol; 2019 Jul; 89():10-23. PubMed ID: 31022415
[TBL] [Abstract][Full Text] [Related]
13. Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes.
Yamaguchi K; Mandai M; Oura T; Matsumura N; Hamanishi J; Baba T; Matsui S; Murphy SK; Konishi I
Oncogene; 2010 Mar; 29(12):1741-52. PubMed ID: 20062075
[TBL] [Abstract][Full Text] [Related]
14. The role of iron in the pathogenesis of endometriosis.
Kobayashi H; Yamada Y; Kanayama S; Furukawa N; Noguchi T; Haruta S; Yoshida S; Sakata M; Sado T; Oi H
Gynecol Endocrinol; 2009 Jan; 25(1):39-52. PubMed ID: 19165662
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.
Kato N; Toukairin M; Asanuma I; Motoyama T
Diagn Cytopathol; 2007 Apr; 35(4):193-7. PubMed ID: 17351940
[TBL] [Abstract][Full Text] [Related]
16. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations.
Munksgaard PS; Blaakaer J
Gynecol Oncol; 2012 Jan; 124(1):164-9. PubMed ID: 22032835
[TBL] [Abstract][Full Text] [Related]
17. Endometriosis and ovarian cancer: a review.
Vlahos NF; Kalampokas T; Fotiou S
Gynecol Endocrinol; 2010 Mar; 26(3):213-9. PubMed ID: 19718562
[TBL] [Abstract][Full Text] [Related]
18. Identification and functions of pattern-recognition receptors.
Kumagai Y; Akira S
J Allergy Clin Immunol; 2010 May; 125(5):985-92. PubMed ID: 20392481
[TBL] [Abstract][Full Text] [Related]
19. Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis.
Furuya M; Yoneyama T; Miyagi E; Tanaka R; Nagahama K; Miyagi Y; Nagashima Y; Hirahara F; Inayama Y; Aoki I
Gynecol Oncol; 2011 Sep; 122(3):648-55. PubMed ID: 21684584
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of endometriosis: the role of initial infection and subsequent sterile inflammation (Review).
Kobayashi H; Higashiura Y; Shigetomi H; Kajihara H
Mol Med Rep; 2014 Jan; 9(1):9-15. PubMed ID: 24173432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]